Episode Details

In his weekly clinical update Dr. Griffin discusses increased acute respiratory illnesses among children and adolescents, estimates of monkeypox incubation period, generation time, and reproduction number, rapid increase in suspected SARS-CoV-2 reinfections, interim infection prevention and control recommendations for healthcare personnel during COVID-19, SARS-CoV-2 secondary attack rates in vaccinated and unvaccinated household contacts during replacement of delta with omicron variant, breakthrough infection by SARS-CoV-2 delta and omicron variants elicited immune response comparable to mRNA booster vaccination, interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses, further humoral immunity evasion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants, short-course early outpatient Remdesivir prevents severe disease due to COVID-19 in organ transplant recipients during the Omicron BA.2 wave, effectiveness of Molnupiravir in high risk patients, and primary care and a distinct symptom pattern for long COVID.

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

• Research assistant position with Amy Rosenfeld (pdf)
• Support MicrobeTV with a Spike t-shirt at Vaccinated.US
• Increase in Acute Respiratory illnesses among children and adolescents (CDC)
• Estimates of Monkeypox incubation period, generation time, reproduction number (CDC)
• Rapid increase in suspected SARS-CoV-2 reinfections (CDC)
• Infection prevention and control recommendations for healthcare providers (CDC)
• SARS-CoV-2 attack rate in vaccinated and unvaccinated household contacts (CDC)
• Breakthrough Infection by variants elicited immune response comparable to vaccine (JID)
• Interval between prior SARS-CoV-2 infection and booster vaccination impacts (CELL)
• Humoral immunity evasion of BA.4 and BA.5 subvariants (The Lancet)